Health Trials

About this trial

Remote healthcare monitoring for cirrhosis has shown promise in overcoming barriers to accessing specialty care, improving healthcare quality, and reducing mortality. The LiverWatch study is investigating whether a remote nutrition, physical activity, and education intervention can improve health outcomes in those with cirrhosis. In this clinical trial, individuals will be randomized to either enhanced usual care or the LiverWatch intervention. Both groups are given fitbits and asked to increase their step counts. Those in the Liverwatch group will be incentivized for increase their physical activity while also undergoing a personalized nutrition intervention and weekly symptom monitoring and cirrhosis education.

Eligibility criteria

Qualifiers

English speaking

Aged 18 years or older

Home-dwelling

Diagnosis of cirrhosis- Child Turcotte-Pugh (CTP) B or C or a complication in the past 6 months (CTP B or higher, hepatic encephalopathy, variceal bleeding, fluid overload, liver-related hospitalization, or requiring symptom management with diuretics, non-absorbable disaccharides, rifaximin, nonselective beta blockers)

Disqualifiers

No access to a smartphone

Non-home dwelling

On hospice care

Model for end stage liver disease (MELD) score ≥30

Trial design

Treatments tested in this trial

  • LiverWatch Intervention

Treatment groups

110 Participants
are divided into 2 treatment groups

Locations

2
University of Michigan48109, Ann ArborMichigan, United States
University of Pennsylvania19104, PhiladelphiaPennsylvania, United States

Sponsors and collaborators

University of Pennsylvania

Lead sponsor

Pennsylvania Department of Health

Collaborator

Source ClinicalTrials.gov